Atria Investments’s Insmed INSM Stock Holding History

Atria Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	12,370 -9,475	-43%	-$1.15M	0.01%	971
2026 Q1	$3.57M	Buy	21,845 +1,460	+7%	+$224K	0.04%	479
2025 Q4	$3.55M	Sell	20,385 -1,028	-5%	-$188K	0.04%	495
2025 Q3	$3.08M	Buy	21,413 +4,603	+27%	+$564K	0.04%	563
2025 Q2	$1.69M	Buy	16,810 +7,219	+75%	+$552K	0.02%	795
2025 Q1	$732K	Buy	9,591 +4,359	+83%	+$333K	0.01%	1140
2024 Q4	$361K	Buy	5,232 +247	+5%	+$17.8K	﹤0.01%	1493
2024 Q3	$364K	Buy	4,985 +1,902	+62%	+$140K	﹤0.01%	1505
2024 Q2	$207K	Buy	+3,083	New	+$120K	﹤0.01%	1807

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Atria Investments's INSM Position: Q2 2026 in Review

Atria Investments reduced its Insmed (INSM) stake by 43% in Q2 2026, selling an estimated $1.15M and leaving 12,370 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #971.

Atria Investments first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.57M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Atria Investments held 12,370 shares of Insmed worth $1.32M as of Q2 2026.
Atria Investments sold 9,475 Insmed shares in Q2 2026, an estimated $1.15M.
Insmed made up 0.01% of Atria Investments's portfolio in Q2 2026, its #971 holding.
Atria Investments first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
Atria Investments's Insmed position peaked at $3.57M in Q1 2026.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.